British & American Investment Trust plc (BAF) Ordinary Shares GBP1
Sell:22.00p
Buy:25.00p
0
Change:
No change
No change
Market closed |
Prices as at close on 22 November 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
- Add to watchlist
- Create an alert
- This stock can be held in a
Sell:22.00p
Buy:25.00p
Change:
No change
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Market closed |
Prices as at close on 22 November 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
Ex-dividend
Sell:22.00p
Buy:25.00p
Change:
No change
No change
Market closed |
Prices as at close on 22 November 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
Ex-dividend
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Objective
The policy is to invest predominantly in investment trusts and other leading UK and US-quoted companies to achieve a balance of income and growth.
| Security | Weight |
|---|---|
| Geron Corp | 46.19% |
| Dunedin Inc Growth Investment Trust Ord 25p | 13.26% |
| Lineage Cell Therapeutics Inc | 7.22% |
| Abrdn Diversified Income & Growth Trust | 4.62% |
| Agex (Usa) | 0.82% |
| ADVFN plc Ordinary Shares 0.2p | 0.30% |
| Audioboom | 0.18% |
| Vodafone | 0.17% |
| Iqe | 0.15% |
| Relief Therapeutics | 0.13% |
| Sector | Weight |
|---|---|
| Healthcare | 53.41% |
| Financial Services | 18.17% |
| Country | Weight |
|---|---|
| United States | 53.41% |
| United Kingdom | 18.17% |
| Germany | 0.17% |
Fee Structure
The Trust is internally managed. The Managing Director has an employment contract with the Company terminable on notice period of 12 months.
Dividend Policy
In 2022, dividends of 1.75 pence per ordinary share and 1.75 pence per preference share were paid as an interim payment during the year. This represented a decrease of 50 percent for ordinary shareholders over the previous year and a yield of approximately 9 percent on the ordinary share price averaged over a period of 12 months.
It is company intention to pay an interim dividend this year as close as possible in amount and on a similar timetable to the dividend paid in 2021, as and when the profitable sales of investments permit.
ASSET SPLIT
Trust Manager
Jonathan Woolf
Manager Bio
Not currently available for this investment trust.
Board Of Directors
David SeligmanChairman, Jonathan Woolf, Julia Le Blan, Alex Tamlyn
Data policy - All information should be used for indicative purposes only. You should
independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete,
and accepts no responsibility for how it may be used.
Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.